Recent Trends in the Surgical Management of Primary Vesicoureteral Reflux in the Era of Dextranomer/Hyaluronic Acid

At freestanding pediatric hospitals enrolled in the PHIS database there is a trend toward decreasing intervention for primary vesicoureteral reflux, which appears to be due to decreased use of injection therapy. This may reflect a philosophical change in reflux management by injection therapy.